Interestingly, the upregulation of CD9, CD63, and CD81 agreed with the previous finding that these three EV markers’ median fluorescence intensity (MFI) on the surface of plasma-derived EVs was significantly higher in PD compared to HC (p < 0.05)100. This evidence concerns the gene CD81 and Parkinson disease.